Report Detail
Global and United States Natural Killer (NK) Cell Therapeutics Market Size, Status and Forecast 2020-2026
- RnM4203658 |
- 14 September, 2020 |
- Global |
- 93 Pages |
- QYResearch |
- Pharma & Healthcare
Global Natural Killer (NK) Cell Therapeutics Scope and Market Size
Natural Killer (NK) Cell Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Natural Killer (NK) Cell Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Mogamulizumab
Lorvotuzumab Mertansine
Others
Market segment by Application, split into
Cancer
Cardiovascular Diseases
Others
Based on regional and country-level analysis, the Natural Killer (NK) Cell Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Natural Killer (NK) Cell Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Mogamulizumab
- 1.2.3 Lorvotuzumab Mertansine
- 1.2.4 Others
- 1.3 Market by Application
- 1.3.1 Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2020 VS 2026
- 1.3.2 Cancer
- 1.3.3 Cardiovascular Diseases
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Natural Killer (NK) Cell Therapeutics Market Perspective (2015-2026)
- 2.2 Global Natural Killer (NK) Cell Therapeutics Growth Trends by Regions
- 2.2.1 Natural Killer (NK) Cell Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Natural Killer (NK) Cell Therapeutics Historic Market Share by Regions (2015-2020)
- 2.2.3 Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Market Size
- 3.1.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue (2015-2020)
- 3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2015-2020)
- 3.2 Global Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Natural Killer (NK) Cell Therapeutics Revenue
- 3.4 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio
- 3.4.1 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Natural Killer (NK) Cell Therapeutics Revenue in 2019
- 3.5 Key Players Natural Killer (NK) Cell Therapeutics Area Served
- 3.6 Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
- 3.7 Date of Enter into Natural Killer (NK) Cell Therapeutics Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer (NK) Cell Therapeutics Breakdown Data by Type (2015-2026)
- 4.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2015-2020)
- 4.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2021-2026)
5 Natural Killer (NK) Cell Therapeutics Breakdown Data by Application (2015-2026)
- 5.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Application (2015-2020)
- 5.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2015-2026)
- 6.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
- 6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)
- 6.4 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size (2015-2026)
- 7.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
- 7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)
- 7.4 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Natural Killer (NK) Cell Therapeutics Market Size (2015-2026)
- 8.2 China Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
- 8.3 China Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)
- 8.4 China Natural Killer (NK) Cell Therapeutics Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Natural Killer (NK) Cell Therapeutics Market Size (2015-2026)
- 9.2 Japan Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
- 9.3 Japan Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)
- 9.4 Japan Natural Killer (NK) Cell Therapeutics Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size (2015-2026)
- 10.2 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size by Type (2015-2020)
- 10.3 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size by Application (2015-2020)
- 10.4 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Chipscreen Biosciences (China)
- 11.1.1 Chipscreen Biosciences (China) Company Details
- 11.1.2 Chipscreen Biosciences (China) Business Overview
- 11.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Introduction
- 11.1.4 Chipscreen Biosciences (China) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020))
- 11.1.5 Chipscreen Biosciences (China) Recent Development
- 11.2 Affimed NV (Netherlands)
- 11.2.1 Affimed NV (Netherlands) Company Details
- 11.2.2 Affimed NV (Netherlands) Business Overview
- 11.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Introduction
- 11.2.4 Affimed NV (Netherlands) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
- 11.2.5 Affimed NV (Netherlands) Recent Development
- 11.3 Altor BioScience Corporation (USA)
- 11.3.1 Altor BioScience Corporation (USA) Company Details
- 11.3.2 Altor BioScience Corporation (USA) Business Overview
- 11.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Introduction
- 11.3.4 Altor BioScience Corporation (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
- 11.3.5 Altor BioScience Corporation (USA) Recent Development
- 11.4 Innate Pharma SA (France)
- 11.4.1 Innate Pharma SA (France) Company Details
- 11.4.2 Innate Pharma SA (France) Business Overview
- 11.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Introduction
- 11.4.4 Innate Pharma SA (France) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
- 11.4.5 Innate Pharma SA (France) Recent Development
- 11.5 Takeda Pharmaceutical (Japan)
- 11.5.1 Takeda Pharmaceutical (Japan) Company Details
- 11.5.2 Takeda Pharmaceutical (Japan) Business Overview
- 11.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Introduction
- 11.5.4 Takeda Pharmaceutical (Japan) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
- 11.5.5 Takeda Pharmaceutical (Japan) Recent Development
- 11.6 Sorrento Therapeutics Inc. (USA)
- 11.6.1 Sorrento Therapeutics Inc. (USA) Company Details
- 11.6.2 Sorrento Therapeutics Inc. (USA) Business Overview
- 11.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Introduction
- 11.6.4 Sorrento Therapeutics Inc. (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
- 11.6.5 Sorrento Therapeutics Inc. (USA) Recent Development
- 11.7 NantKwest Inc. (USA)
- 11.7.1 NantKwest Inc. (USA) Company Details
- 11.7.2 NantKwest Inc. (USA) Business Overview
- 11.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Introduction
- 11.7.4 NantKwest Inc. (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
- 11.7.5 NantKwest Inc. (USA) Recent Development
- 11.8 Bristol-Myers Squibb (USA)
- 11.8.1 Bristol-Myers Squibb (USA) Company Details
- 11.8.2 Bristol-Myers Squibb (USA) Business Overview
- 11.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Introduction
- 11.8.4 Bristol-Myers Squibb (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
- 11.8.5 Bristol-Myers Squibb (USA) Recent Development
- 11.9 NKT Therapeutics (USA)
- 11.9.1 NKT Therapeutics (USA) Company Details
- 11.9.2 NKT Therapeutics (USA) Business Overview
- 11.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Introduction
- 11.9.4 NKT Therapeutics (USA) Revenue in Natural Killer (NK) Cell Therapeutics Business (2015-2020)
- 11.9.5 NKT Therapeutics (USA) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Natural Killer (NK) Cell Therapeutics. Industry analysis & Market Report on Natural Killer (NK) Cell Therapeutics is a syndicated market report, published as Global and United States Natural Killer (NK) Cell Therapeutics Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Natural Killer (NK) Cell Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
